Mouse, Rat, Rabbit, Horse, Guinea pig, Cow, Cat, Dog
Synthetic peptide corresponding to a peptide within the N terminal amino acids 71-120 of Human MFAP4: MTTEGGKWTV FQKRFNGSVS FFRGWNDYKL GFGRADGEYW LGLQNMHLLT , corresponding to N terminal amino acids 71-120 of Human MFAP4
Shipped at 4°C. After reconstitution store at -20ºC. Avoid freeze / thaw cycles.
Constituents: 2% Sucrose, PBS
Concentration information loading...
Immunogen affinity purified
Immunizing Peptide (Blocking)
Abpromise guarantee covers the use of
in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Use a concentration of 1 µg/ml. Predicted molecular weight: 29 kDa.Can be blocked with
MFAP4 peptide (ab195539). Good results were obtained when blocked with 5% non-fat dry milk in 0.05% PBS-T.
Could be involved in calcium-dependent cell adhesion or intercellular interactions.
MFAP4 is deleted in the Smith-Magenis syndrome (SMS) [MIM:182290].
Contains 1 fibrinogen C-terminal domain.
Secreted > extracellular space > extracellular matrix.
Information by UniProt
Microfibril-associated glycoprotein 4 antibody
Microfibrillar associated protein 4 antibody
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MFAP4 antibody (ab80319)
Sample Type : Mouse sciatic nerve. Primary Antibody Dilution : 1:500. Secondary Antibody : Biotinylated Anti-Rabbit 1:1000 followed by avidin-biotin and diaminobenzidine. Secondary Antibody Dilution : 1:1000. Gene Name : MFAP4.
Western blot - MFAP4 antibody (ab80319)
Anti-MFAP4 antibody (ab80319) at 1 µg/ml + MCF7 cell lysate at 10 µg
Secondary HRP conjugated anti-Rabbit IgG at 1/100000 dilution Predicted band size: 29 kDa Gel contration: 12%
has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"